|
|
||||||||
Basic Science Investigations |
PET Imaging Science Center, Department of Radiology, University of Southern California, Los Angeles, California
2'-Deoxy-2'-18F-fluoro-5-fluoro-1-ß-D-arabinofuranosyluracil (18F-FFAU) has been synthesized and evaluated in HT-29 cells as a potential PET agent for herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene expression. Methods: 2-Deoxy-2-18F-fluoro-1,3,5-tri-O-benzoyl-
-D-arabinofuranose was prepared by the reaction of the respective 2-triflate with tetrabutylammonium 18F-fluoride. The fluorosugar was converted to its 1-bromo derivative and coupled with protected 5-fluorouracil. The crude product was hydrolyzed in base and purified by high-performance liquid chromatography to obtain the 18F-FFAU. In vitro studies were performed in HT-29 cells by incubation at various time points. In vivo studies including biodistribution and microPET were performed in tumor-bearing nude mice. Results: The radiochemical yield was 20%30% decay corrected with an average of 25% in 4 runs. Radiochemical purity was >99% and average specific activity was 85 GBq/µmol (2,300 mCi/µmol) (end of synthesis). In vitro accumulation of 3H-FFAU in HSV1-tkexpressing cells was
180-fold (P < 0.001) higher than that in the wild-type cells between 30 and 120 min. In vivo uptake of 3H-FFAU in HSV1-tkpositive tumors at 2 h was
8-fold (P < 0.001) higher than that in the control tumors. Tumor uptake (percentage injected dose per gram of tissue) and the uptake ratio (tk-positive to wild type) of 3H-FFAU in tk-positive cells was higher compared with those of our earlier studies using 2'-14C-deoxy-2'-fluoro-5-methyl-1-ß-D-arabinofuranosyluracil (14C-FMAU) and 9-(4-18F-fluoro-3-hydroxymethylbutyl)guanine (18F-FHBG) in the same cell lines. microPET on tumor-bearing nude mice also demonstrated a very high uptake of 18F-FFAU in tk-positive tumors compared with that of the control tumor without significant accumulation in other organs. Conclusion: These results demonstrate that 18F-FFAU has superior biodistribution characteristics and significantly higher in vivo uptake in HSV1-tkexpressing tumor compared with previously studied agents.
Key Words: 2'-deoxy-2'-18F-fluoro-5-fluoro-1-ß-D-arabinofuranosyluracil herpes simplex virus type-1 thymidine kinase HT-29 cells PET gene expression
Related articles in JNM:
This article has been cited by other articles:
![]() |
T. Miyagawa, G. Gogiberidze, I. Serganova, S. Cai, J. A. Balatoni, H. T. Thaler, L. Ageyeva, N. Pillarsetty, R. D. Finn, and R. G. Blasberg Imaging of HSV-tk Reporter Gene Expression: Comparison Between [18F]FEAU, [18F]FFEAU, and Other Imaging Probes J. Nucl. Med., April 1, 2008; 49(4): 637 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Cho, J. Polster, J. M. Engles, J. Hilton, E. H. Abraham, and R. L. Wahl In Vitro Evaluation of Adenosine 5'-Monophosphate as an Imaging Agent of Tumor Metabolism J. Nucl. Med., May 1, 2006; 47(5): 837 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kelloff, K. A. Krohn, S. M. Larson, R. Weissleder, D. A. Mankoff, J. M. Hoffman, J. M. Link, K. Z. Guyton, W. C. Eckelman, H. I. Scher, et al. The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development Clin. Cancer Res., November 15, 2005; 11(22): 7967 - 7985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Hung, W.-P. Deng, W. K. Yang, R.-S. Liu, C.-C. Lee, T.-C. Su, R.-J. Lin, D.-M. Yang, C.-W. Chang, W.-H. Chen, et al. Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging Clin. Cancer Res., November 1, 2005; 11(21): 7749 - 7756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |